Smith & Nephew SNATS Inc ADR (SNN)

Smith & Nephew SNATS Inc ADR is a depositary receipt listed on the NYSE that represents common stock of Smith & Nephew plc. The underlying issuer is a healthcare company that develops, manufactures, markets, and sells medical devices and related services in the United Kingdom, the United States, and international markets. Its business is organized into three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.

The Orthopaedics segment includes knee and hip implants, as well as trauma, extremities, and other reconstruction products. Sports Medicine & ENT covers products and technologies used in minimally invasive procedures, soft tissue repair, arthroscopic visualization, and ear, nose, and throat care. Advanced Wound Management provides products and technologies for acute and chronic wound treatment, including negative pressure wound therapy, bioactives, regenerative medicine products, and hydrosurgery systems. The company serves healthcare providers and is headquartered in Watford, United Kingdom.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-SNN
$39.42
26.0% Upside
Undervalued
$33.19
6.1% Upside
Fair
Great
2.5%
March 1, 2027
20.5x
2.5x
2.1x
13.013 B
16.044 B
22.6%
99.0%
10.0
52.4%
134.6%
Valuation • Fair Value

Smith & Nephew SNATS Inc ADR (NYSE-SNN) Fair Value by Valuation Model

Review the available estimates for Smith & Nephew SNATS Inc ADR (NYSE-SNN), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$39.42

Estimated upside of 26.0% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$41.88

Discounted cash flow valuation reference.

Ben Graham Formula Value

$17.06

Classic Ben Graham valuation formula reference.

DDM Fair Value

$48.24

Dividend discount model valuation reference.

EPV Fair Value

$29.86

Earnings power value estimate.

Comps Fair Value

$35.62

Comparable-company valuation reference.

Analyst Price Target

$33.19

Analysts imply upside of 6.1%.

How to read these valuation models

Use the 8 available valuation references for Smith & Nephew SNATS Inc ADR (NYSE-SNN) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Smith & Nephew SNATS Inc ADR (NYSE-SNN)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

6.3 B

Current operating scale indicator.

Revenue Forecast

6.408 B

Forward revenue estimate.

EBITDA

1.382 B

Current operating profitability reference.

EBITDA Forecast

1.666 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Smith & Nephew SNATS Inc ADR (NYSE-SNN) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Smith & Nephew SNATS Inc ADR (NYSE-SNN)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.75

No elevated caution signal from this screen.

Altman Z-Score

10.0

Relatively strong balance-sheet zone.

FCF / Net Income

134.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Smith & Nephew SNATS Inc ADR (NYSE-SNN). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Smith & Nephew SNATS Inc ADR (NYSE-SNN)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

March 1, 2027

Days to Earnings

108

Dividend Yield

2.5%

Current income yield reference.

Payout Ratio

52.4%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Smith & Nephew SNATS Inc ADR (NYSE-SNN), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Smith & Nephew SNATS Inc ADR (NYSE-SNN) Stock Forecast & Technical Outlook

Review Smith & Nephew SNATS Inc ADR (NYSE-SNN) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Smith & Nephew SNATS Inc ADR (NYSE-SNN)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Smith & Nephew SNATS Inc ADR (NYSE-SNN) has a Hold consensus, with 0 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 5
Sell 0
FAQ • Fast Investor Answers

Smith & Nephew SNATS Inc ADR (NYSE-SNN) Stock FAQ

Data-supported answers about Smith & Nephew SNATS Inc ADR (NYSE-SNN), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$39.42
Estimated upside 26.0%
Valuation Rating
Undervalued
Estimated upside of 26.0%
Analyst Target
$33.19
Implied upside 6.1%
Financial Health
Great
Current financial-health read

The current fair value estimate for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is $39.42. This implies an estimated upside of 26.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 26.0% versus the current market price.

The available analyst price target for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is $33.19. The analyst target implies estimated upside of 6.1%.

The current financial health read for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is March 1, 2027.

Based on the current data, dividend yield is 2.5%.

The current P/E ratio listed for Smith & Nephew SNATS Inc ADR (NYSE-SNN) is 20.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Smith & Nephew SNATS Inc ADR is 13.013 B.

The current enterprise value listed for Smith & Nephew SNATS Inc ADR is 16.044 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Smith & Nephew SNATS Inc ADR is NYSE-SNN, and the stock is listed on NYSE.

Smith & Nephew SNATS Inc ADR (NYSE-SNN) is listed on NYSE.

The current debt-to-total-capital ratio listed for Smith & Nephew SNATS Inc ADR is 22.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Smith & Nephew SNATS Inc ADR is 99.0%. Free float helps investors understand how much of the share base is available for public trading.